Le Lézard
Classified in: Health
Subject: SVY

Global Wearable Patch Market to Surpass US$ 1,660.5 Million by 2027 - Coherent Market Insights


SEATTLE, Jan. 27, 2020 /PRNewswire/ -- According to Coherent Market Insights, the global wearable patch market is estimated to be valued at US$ 318.1 million in 2019, and is expected to exhibit a CAGR of 22.9% over the forecast period (2019-2027).

Coherent Market Insights Logo

Key Trends and Analysis of the Global Wearable Patch Market:

Key trends in market include increasing incidences of chronic disease such as diabetes and cardiac disorder, increasing number of product launches, and increasing collaboration and acquisition activities by key market players.

According to the International Diabetes Federation's reports published in November 2019, around 463 million adults between the age group of 20 to 79 years were diagnosed with diabetes globally and it is expected that the total diabetes population will reach around 700 million by 2045.

Request for Sample PDF copy @ https://www.coherentmarketinsights.com/insight/request-sample/2891

Furthermore, according to latest reports published in October 2019, by Johnson & Johnson Medical Devices Companies, prevalence of atrial fibrillation (AF) in Asia Pacific is increasing rapidly and affects nearly 16 million individuals in 2017, which is expected to reach 72 million by 2050

Increasing product launches is expected to drive growth of the global wearable patch market over the forecast period. For instance, in March 2019, Vivalnk, Inc. launched internet of things (IoT) -enabled medical wearable sensor platform with edge computing technology, and an internet of health things (IoHT) data cloud. The software platform is designed to capture human vitals and biometrics from patients and transfer data for analysis.

Furthermore, key players operating in the market are focused on adopting acquisition and collaboration strategies, in order to expand their product offerings in markets. For instance, in September 2019, Abbott Laboratories entered into collaboration with Sanofi for the development of tool that integrates its respective blood sugar tracking and insulin delivery technologies. The collaboration aimed at combining Abbott's FreeStyle Libre, a continuous glucose monitoring system with Sanofi's background in insulin dosing, into new compatible devices developed for regulatory approval in the near future.

Key Market Takeaways:

Key players operating in the global wearable patch market include --

Medtronic Plc, Hill-Rom Holdings, Inc. (Welch Allyn), iRhythm Technologies, Inc., AliveCor, Inc., Vivalnk, Inc., Cardiac Insight Inc., VitalConnect, LifeSignals, Inc., L'oreal Group, Dexcom, Inc., GENTAG, Inc., Abbott Laboratories, and  Koninklijke Philips N.V.

Buy this Report (Single User License) @ https://www.coherentmarketinsights.com/insight/buy-now/2891 

Market Segmentations:

Didn't find what you were looking for? Get Insights on similar topics:

Diclofenac Patches Market

Diclofenac patches market is expected to witness significant growth over the forecast period, owing to high prevalence of chronic pain disease. According to the American Academy of Pain Medicine (AAPM), in 2011, around 1.8 billion people suffered from chronic pain.

Read more details @ https://www.coherentmarketinsights.com/ongoing-insight/diclofenac-patches-market-1792 

Lidocaine Patches Market

Increasing number generic approved product in the market are expected to augment the lidocaine patches market growth. Patent expiry of Endo Pharmaceuticals for Lidoderm offers growth opportunity for market players to develop generic version of the lidocaine patch. For instance, in 2015, Mylan Pharmaceuticals, Inc., launched the generic version of Endo Pharmaceutical's Lidoderm in the U.S. market. In 2014, Galen US Incorporated receive FDA approval for Synera, lidocaine and tetracaine topical patch for domestic use.

Read more details @ https://www.coherentmarketinsights.com/ongoing-insight/lidocaine-patches-market-1805 

Body Worn Insect Repellent Products Market

According to Centers for Disease Control and Prevention (CDC), Lyme disease is the fastest growing vector-borne disease in the U.S. and it affects around 300,000 people every year, out of which 25% of the patients are children. Also, in 2015, around 2.35 million dengue fever cases were reported in America causing 1181 deaths and continues to affect several other regions such as Asia Pacific and Europe, as per the World Health Organization (WHO).

Read more details @ https://www.coherentmarketinsights.com/ongoing-insight/body-worn-insect-repellent-products-market-1407 

Contact Us:
Mr. Raj Shah
Coherent Market Insights
1001 4th Ave. 
#3200 
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]

 

SOURCE Coherent Market Insights


These press releases may also interest you

at 14:05
Yoneda Labs, the Y Combinator startup building a foundation model for chemists working in drug discovery, today announced it has raised $4 million in seed capital from Khosla Ventures, 500 Emerging Europe, 468 Capital, Fellows Fund, and Y Combinator....

at 14:00
People USA, funded by and in partnership with the New York State Office of Mental Health (OMH), is set to open 20 new scattered site housing units that will support individuals re-entering the community from New...

at 13:45
Harbor Point at Centerville, a Benchmark Mind & Memory Care community, has ranked among the best assisted living with memory care communities in Massachusetts and the entire U.S. for the third straight year. In U.S. News & World Report's third annual...

at 13:45
Crescent Point at Niantic, a Benchmark assisted living and Mind & Memory Care community, has ranked among the best assisted living with memory care communities in Connecticut and the entire U.S. for the third straight year. In U.S. News & World...

at 13:22
Houston, we don't have a foot care problem ? now that Modern Foot & Ankle has moved into the Lone Star State. The podiatric group originated in Florida and has a strong presence in Tampa, Orlando, and Palm Beach. But with its recent acquisition of a...

at 13:05
Gestalt Diagnostics has added healthcare industry expert, Dr. J. Mark Tuthill, to serve on Gestalt's Advisory Board. He will be joining Gestalt's distinguished Advisory Board of pathologists contributing to oversight and active input of development...



News published on and distributed by: